These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17339105

  • 1. Structural characterization of insulin NPH formulations.
    Norrman M, Hubálek F, Schluckebier G.
    Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
    [Abstract] [Full Text] [Related]

  • 2. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
    Yanagisawa K.
    Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
    [Abstract] [Full Text] [Related]

  • 3. Structural interpretation of reduced insulin activity as seen in the crystal structure of human Arg-insulin.
    Sreekanth R, Pattabhi V, Rajan SS.
    Biochimie; 2008 Mar; 90(3):467-73. PubMed ID: 18029081
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
    DeFelippis MR, Bakaysa DL, Bell MA, Heady MA, Li S, Pye S, Youngman KM, Radziuk J, Frank BH.
    J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
    [Abstract] [Full Text] [Related]

  • 5. Structural studies of a crystalline insulin analog complex with protamine by atomic force microscopy.
    Yip CM, Brader ML, Frank BH, DeFelippis MR, Ward MD.
    Biophys J; 2000 Jan; 78(1):466-73. PubMed ID: 10620310
    [Abstract] [Full Text] [Related]

  • 6. Crystal structure of ultralente--a microcrystalline insulin suspension.
    Wagner A, Diez J, Schulze-Briese C, Schluckebier G.
    Proteins; 2009 Mar; 74(4):1018-27. PubMed ID: 18767151
    [Abstract] [Full Text] [Related]

  • 7. A novel protein cross-linking reaction in stressed Neutral Protamine Hagedorn formulations of insulin.
    Beavis RC, Kneirman MD, Sharknas D, Heady MA, Frank BH, DeFelippis MR.
    J Pharm Sci; 1999 Mar; 88(3):331-6. PubMed ID: 10052992
    [Abstract] [Full Text] [Related]

  • 8. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C, Castillo R, Quiralte J, Delgado J, García I, de Pablos P, Carrillo T.
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [Abstract] [Full Text] [Related]

  • 9. Reversible adsorption of soluble hexameric insulin onto the surface of insulin crystals cocrystallized with protamine: an electrostatic interaction.
    Dodd SW, Havel HA, Kovach PM, Lakshminarayan C, Redmon MP, Sargeant CM, Sullivan GR, Beals JM.
    Pharm Res; 1995 Jan; 12(1):60-8. PubMed ID: 7724489
    [Abstract] [Full Text] [Related]

  • 10. Structure of the putative thioesterase protein TTHA1846 from Thermus thermophilus HB8 complexed with coenzyme A and a zinc ion.
    Hosaka T, Murayama K, Kato-Murayama M, Urushibata A, Akasaka R, Terada T, Shirouzu M, Kuramitsu S, Yokoyama S.
    Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):767-76. PubMed ID: 19622860
    [Abstract] [Full Text] [Related]

  • 11. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J, Schreyen H, Dorchy H.
    Diabete Metab; 1992 Aug; 18(4):272-6. PubMed ID: 1459314
    [Abstract] [Full Text] [Related]

  • 12. Crystal structure of a prolonged-acting insulin with albumin-binding properties.
    Whittingham JL, Havelund S, Jonassen I.
    Biochemistry; 1997 Mar 11; 36(10):2826-31. PubMed ID: 9062110
    [Abstract] [Full Text] [Related]

  • 13. Structure of porcine insulin cocrystallized with clupeine Z.
    Balschmidt P, Hansen FB, Dodson EJ, Dodson GG, Korber F.
    Acta Crystallogr B; 1991 Dec 01; 47 ( Pt 6)():975-86. PubMed ID: 1772633
    [Abstract] [Full Text] [Related]

  • 14. Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.
    Zöllner H, Jouni R, Panzer S, Khadour A, Janzen L, Wesche J, Ten Berg M, Schellong S, Heinken A, Greinacher A, Bakchoul T.
    J Thromb Haemost; 2017 Jan 01; 15(1):176-184. PubMed ID: 27759896
    [Abstract] [Full Text] [Related]

  • 15. Computational Approach to Elucidating Insulin-Protamine Binding Interactions and Dynamics in Insulin NPH Formulations.
    Rohilla KK, Pandey MK.
    ACS Omega; 2024 Jan 30; 9(4):4857-4869. PubMed ID: 38313521
    [Abstract] [Full Text] [Related]

  • 16. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M, Tapanainen P, Veijola R.
    Pediatr Diabetes; 2008 Jun 30; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M.
    Diabet Med; 2008 Aug 30; 25(8):916-23. PubMed ID: 18959604
    [Abstract] [Full Text] [Related]

  • 20. Hybrid insulin cocrystals for controlled release delivery.
    Brader ML, Sukumar M, Pekar AH, McClellan DS, Chance RE, Flora DB, Cox AL, Irwin L, Myers SR.
    Nat Biotechnol; 2002 Aug 30; 20(8):800-4. PubMed ID: 12134168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.